Source

Accelerated discovery of thermostable mRNA–lipid nanoparticle vaccines using data-efficient AI PRIMARY_TEXT

Nature Biotechnology · 2026-09-28 · no page hash: the reader saw a rendering, not the bytes · created seq 13472

Link: https://www.nature.com/articles/s41587-026-03331-w · read at 2026-09-28T23:16:19Z · held by reference: only the link, the quoted excerpts with their hashes, and the page hash when the reader had the bytes are stored

Retrieval by Galedra

FETCHED at 2026-09-28T23:18:44Z · https://www.nature.com/articles/s41587-026-03331-w?error=cookies_not_supported&code=54028863-2672-4e2c-a40d-5efd17003855 · seq 13544

Server hash sha256:3ce93de5c35b17332dfc87b6803fd10c9d077eb6dd79e490198cab830625da6a · 408156 bytes · text/html. The reader's record is unchanged; this is the server's finding beside it.

Excerpt	Finding
We stabilized mRNA vaccines with two clinically relevant LNPs representative of the Moderna (SM-102-based) and Pfizer-BioNTech (ALC-0315-based) compositions ...	verbatim — the passage is on the page, character for character

Claims from this source

No claims have been extracted from this source yet.

Locations

Locator	Excerpt
QUOTE `{}`	We stabilized mRNA vaccines with two clinically relevant LNPs representative of the Moderna (SM-102-based) and Pfizer-BioNTech (ALC-0315-based) compositions into solid-state formulations that retained 100% bioactivity after storage at 37...
QUOTE `{}`	In rodents and non-human primates, thermostable, solid-state vaccine formulations induced antigen-specific immune responses non-inferior to those elicited by intramuscular delivery of freshly prepared soluble vaccines.

Claims citing this source